Connect with licensed healthcare providers through Klarity Health to evaluate your condition and receive an Entresto prescription online within 24 hours, ensuring personalized, confidential, and HIPAA-compliant care.
Heart failure is a serious condition where the heart's ability to pump blood effectively is compromised. Entresto (sacubitril/valsartan) has been FDA-approved to help reduce the risk of death and hospitalization in patients with chronic heart failure with reduced ejection fraction (HFrEF). This medication works by combining two active ingredients that help relax blood vessels and improve heart function.
Entresto is a dual-action medication (ARNi) that inhibits neprilysin and blocks angiotensin II receptors. This unique mechanism offers better outcomes compared to traditional treatments like ACE inhibitors or ARBs alone. It reduces strain on the heart and improves survival rates in eligible patients.
Adults with chronic heart failure with reduced ejection fraction can benefit from Entresto. It is also approved for pediatric patients aged 1 year and older with symptomatic heart failure. Your healthcare provider will assess if you are a suitable candidate.
Getting started involves a simple process:
Entresto offers a dual-action approach (ARNi) that has been proven to lower the risk of cardiovascular death and hospitalization more effectively than ACE inhibitors alone. It may cause low blood pressure and requires monitoring of kidney function and potassium levels. Compared to other medications, Entresto provides additional survival benefits in heart failure management.
Klarity Health connects you with experienced, board-certified healthcare professionals who specialize in heart failure treatment. Appointments are typically available within 24 hours, and you can access confidential, personalized care from the comfort of your home. You can also manage ongoing support and follow-up care easily.
Our providers include licensed practitioners such as:
Read real patient stories demonstrating successful treatment and management of heart failure and related conditions via Klarity’s virtual care platform.
All evaluations and prescriptions are provided by independent licensed practitioners. A diagnosis, treatment plan, or prescription is not guaranteed. Some medications, especially controlled substances, may require in-person evaluation depending on state regulations. Your privacy and information security are prioritized, with all data HIPAA compliant.
Entresto is prescribed to reduce risks of cardiovascular death and hospitalization in adults with chronic heart failure with reduced ejection fraction.
By scheduling a virtual consultation with a licensed provider on Klarity, who will evaluate your condition and prescribe if appropriate, all within 24 hours.
Common side effects include low blood pressure, dizziness, kidney issues, and cough. Consult your provider for personalized advice and monitoring during treatment.
Yes, Entresto can lower blood pressure, which may cause hypotension; proper monitoring is essential during therapy.
To begin your evaluation or to schedule an appointment, visit Klarity’s platform and select your state. No in-person visit is necessary unless required by local regulations. Your provider will guide you through the process and discuss treatment options.